Clinical trial
Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations…
NCT00306982 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00306982 |
|---|---|
| Title | Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™ |
| Official title | An Observational Study to Investigate the Incidence of Influenza, Downstream Complications of Influenza and Hospitalizations, in Elderly Subjects Vaccinated With GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix |
| Enrollment | 1,524 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 27, 2006 |
| Last update posted | Oct 12, 2016 |
| Countries | Australia, Brazil |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: